Confronto

Carbetocin vs. Cetrorelix

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

37025-55-1

120287-85-6

Peso molecolare

nessun dato

1431.06 g/mol

Emivita

0.67 h

nessun dato

Sequenza

nessun dato

Meccanismo d'azione

Carbetocin

Carbetocin is an oxytocin receptor agonist with prolonged duration. It triggers a sustained contraction of the uterus after birth, preventing atonic hemorrhage — unlike oxytocin, without a multi-hour infusion.

Cetrorelix

Cetrorelix competitively and immediately blocks the pituitary GnRH receptor, rapidly suppressing LH and FSH release — without the initial hormone surge ('flare') of GnRH agonists.

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Carbetocin	Cetrorelix
Germania	Su prescrizione	Su prescrizione
Stati Uniti	Non approvato	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Carbetocin and Cetrorelix?: Carbetocin is classified as "Ricerca (altro)", while Cetrorelix is classified as "Ricerca (altro)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Cetrorelix: Cetrorelix is a synthetic decapeptide and GnRH antagonist. It is used in assisted reproduction (IVF) to prevent a premature LH surge during controlled ovarian stimulation. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Carbetocin or Cetrorelix?: The highest available evidence level is "RCT sull'uomo" for Carbetocin and "RCT sull'uomo" for Cetrorelix. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Carbetocin and Cetrorelix in Germany and the United States?: Germania: Carbetocin — Su prescrizione, Cetrorelix — Su prescrizione. Stati Uniti: Carbetocin — Non approvato, Cetrorelix — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Carbetocin

Cetrorelix

Germania

Su prescrizione

Stati Uniti

Non approvato

Su prescrizione

Frequently asked questions

What is the difference between Carbetocin and Cetrorelix?

Carbetocin is classified as "Ricerca (altro)", while Cetrorelix is classified as "Ricerca (altro)". Carbetocin: Carbetocin is a long-acting synthetic oxytocin analog (half-life ~40 minutes). It prevents postpartum hemorrhage as a single injection. Approved in Canada and the UK among others, NOT in the US. Cetrorelix: Cetrorelix is a synthetic decapeptide and GnRH antagonist. It is used in assisted reproduction (IVF) to prevent a premature LH surge during controlled ovarian stimulation. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Carbetocin or Cetrorelix?

The highest available evidence level is "RCT sull'uomo" for Carbetocin and "RCT sull'uomo" for Cetrorelix. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Carbetocin and Cetrorelix in Germany and the United States?

Germania: Carbetocin — Su prescrizione, Cetrorelix — Su prescrizione. Stati Uniti: Carbetocin — Non approvato, Cetrorelix — Su prescrizione. These are factual summaries with source and review date on the individual pages.